Live Breaking News & Updates on இன்சுலின் பேனா|Page 7

Stay updated with breaking news from இன்சுலின் பேனா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hundreds received affordable insulin under new Minnesota program

Hundreds of Minnesotans with diabetes received life-saving medication at low cost in the first six months of the state's new emergency insulin law, according to a new report from the Minnesota Board of Pharmacy. The backdrop: The Alec Smith Insulin Affordability Act, which passed with bipartisan support last year, ensures access to a 30-day supply of insulin for a $35 co-pay. The cost of the long-term program is $50 every three months.Get market news worthy of your time with Axios Markets. Subscribe for free.The goal of the bill, named after a 26-year-old who died after rationing his medicine, was to save people from risking their health over cost concerns. By the numbers: More than 200 residents were able to access the 30-day supply.Hundreds more enrolled in a program requiring manufacturers to provide insulin to low-income residents at reduced price for up to a year.The bill, which the pharmaceutical industry is challenging in court, cost manufacturers more than $2 million betwe ....

Minnesota Board Of Pharmacy , Axios Markets , Bipartisan Support , மினசோட்டா பலகை ஆஃப் மருந்தகம் , அச்சுக்கள் சந்தைகள் ,

One of the World's Most Venomous Animals Is a Snail


The Atlantic
They lure their prey with the promise of sex and then kill them cold.
Paulo Oliveira / Alamy
The aptly named cone snail wears a house that resembles a Ben & Jerry’s receptacle, filled not with ice cream but with a squishy mollusk that sports an extendable, trunklike proboscis. The snails are superficially docile creatures, and can be painfully shy; sometimes they go weeks in a lab without taking a single bite of food, cringing at the slightest change in temperature, lighting, or human supervision. “These are not racing snails,” says Eric Schmidt, a biochemist at the University of Utah. ....

Zhenjian Lin , Fiona Cross , University Of Utah , University Of Canterbury , Hunter College , Cone Snail , Victims Of Cone Snail Venom , Snail Species , Species Of Cone Snails , Cone Snails , Joshua Torres , Good Measure , Pheromones Of Their Prey , Squishy Mollusk , Cone Snails Devious Antics , Speediest Fish , Marine Worms , Geographer Cone Snail , Recent Years , Worm Hunting Cone Snails , Chemical Cocktails , Human Supervision , Torress Postdoctoral Adviser , Modus Operandi , Hapless Fish , Bolus Of Toxins ,

Translational research results in promising combination therapeutic candidate for type 1 diabetes


Translational research results in promising combination therapeutic candidate for type 1 diabetes
Translational research led by scientists at La Jolla Institute for Immunology (LJI) has resulted in a promising combination therapeutic candidate for adults with recent-onset type 1 diabetes.
The combination therapy was recently tested in a randomised, double-blind, placebo- controlled, phase 2 trial run and funded by pharmaceutical company Novo Nordisk. The results, published recently in
The Lancet Diabetes and Endocrinology, point to a potential way to treat the autoimmune disease without leaving the body vulnerable to infectious disease.
The therapeutic candidate combines anti-IL-21 antibody with the diabetes drug liraglutide. This two-pronged approach is based on research findings from the lab of LJI Professor Matthias von Herrath, M.D., who also serves as vice president and senior medical officer, Global Chief Medical Office, at Novo Nordisk. ....

Emily Henderson , Herrath Laboratory , Jolla Institute For Immunology , Jolla Institute , Novo Nordisk , Lancet Diabetes , Global Chief Medical Office , Type 1 Diabetes , Autoimmune Disease , Immune System , Type 2 Diabetes , எமிலி ஹென்டர்சன் , ஜொல்லா நிறுவனம் க்கு நோயெதிர்ப்பு , ஜொல்லா நிறுவனம் , உலகளாவிய தலைமை மருத்துவ அலுவலகம் , நீரிழிவு நோய் , ஆட்டோ இம்யூன் நோய் , நோய் எதிர்ப்பு சக்தி அமைப்பு ,

To pay for infrastructure, Democrats mull major changes to drug pricing


Jeffrey Greenberg/Education Images/Universal Images Group via Getty Images
This story is available exclusively to Insider subscribers.
Become an Insider and start reading now.
Democrats are mulling including a provision to negotiate drug prices in an infrastructure bill.
Savings on government spending on prescription drugs could help pay for the infrastructure projects.
The government could save as much as $345 billion, according to the Congressional Budget Office.
Congressional Democrats want to crack down on drug prices to help pay for President Joe Biden s infrastructure package, according to several lawmakers, including House Speaker Nancy Pelosi. 
Such a provision would be included in a package that lawmakers hope to pass as early as July 4 if they can gain enough support for it. ....

United States , White House , District Of Columbia , Capitol Hill , West Virginia , Janet Yellen , Ron Wyden , Donald Trump , Chuck Grassley , Joe Biden , Kyrsten Sinema , Spencer Perlman , Joe Manchin , Ron Klain , John Yarmuth , Steny Hoyer , Democrats In Congress , Human Services , Senate Finance Committee , Senate Budget Committee , Department Of Health , Congressional Budget Office , House Budget Committee , Congressional Budget , President Joe Biden , House Majority Leader Steny Hoyer ,